UK Modern Slavery Act Statement 2016 - Novartis · 2017-05-31 · (including members of the...

4

Transcript of UK Modern Slavery Act Statement 2016 - Novartis · 2017-05-31 · (including members of the...

Page 1: UK Modern Slavery Act Statement 2016 - Novartis · 2017-05-31 · (including members of the Executive Committee of Novartis) completed the course. This represents 98% of the invited
Page 2: UK Modern Slavery Act Statement 2016 - Novartis · 2017-05-31 · (including members of the Executive Committee of Novartis) completed the course. This represents 98% of the invited
Page 3: UK Modern Slavery Act Statement 2016 - Novartis · 2017-05-31 · (including members of the Executive Committee of Novartis) completed the course. This represents 98% of the invited
Page 4: UK Modern Slavery Act Statement 2016 - Novartis · 2017-05-31 · (including members of the Executive Committee of Novartis) completed the course. This represents 98% of the invited

Novartis Live Magazine_March2017

Novartis Live Magazine_March2017

Slavery and Anti-Slavery: Part III: The Institution of Slavery

Slavery and Anti-Slavery: Part III: The Institution of Slavery

Novartis India Limited

Novartis India Limited

Novartis Foundation

Novartis Foundation

Novartis Environment Awards 2012

Novartis Environment Awards 2012

Novartis 2012

Novartis 2012

Exforge - Novartis Pharma

Exforge - Novartis Pharma

B2 novartis

B2 novartis

Corporate governance - Novartis

Corporate governance - Novartis

Report on Novartis

Report on Novartis

PRODUCT MONOGRAPH - Novartis

PRODUCT MONOGRAPH - Novartis

Vademecum Novartis

Vademecum Novartis

Novartis Access

Novartis Access

SAFETY NOTICE - Novartis

SAFETY NOTICE - Novartis

Novartis Pharma Assignment

Novartis Pharma Assignment

가브스메트 - Novartis

가브스메트 - Novartis

Novartis Methodological Note

Novartis Methodological Note

Novartis india

Novartis india

UK Modern Slavery Act Statement 2016 - Novartis · suppliers that pose elevated risks. In 2016, 178 suppliers were identified in the first stage of our process as posing a significant

UK Modern Slavery Act Statement 2016 - Novartis · suppliers that pose elevated risks. In 2016, 178 suppliers were identified in the first stage of our process as posing a significant

Presentation - Novartis

Presentation - Novartis